Results of a phase I–II study of adjuvant concurrent carboplatin and accelerated radiotherapy for triple negative breast cancer

DOI: 10.1080/2162402X.2016.1274479

Keywords: Adjuvant treatment, chemo-radiation, clinical trial, immunogenic cell death, triple negative breast cancer, tumor-infiltrating lymphocytes

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text